For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney ...
Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE ...
Toronto, ON - A new meta-analysis comparing angiotensin receptor blockers (ARBs) to placebo or ACE inhibitors in heart failure patients "cannot claim that ARBs are superior" to ACE inhibitors in ...
The benefit of angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) has been established in patients with left ventricular (LV) systolic dysfunction 1. It is ...
Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...
Morning Overview on MSN
A common blood-pressure pill may be quietly speeding kidney damage in diabetics
Three large randomized trials tested a simple idea: if one blood-pressure drug that blocks the renin-angiotensin system ...
Cardiovascular disease (CVD) is the leading cause of non-cancer mortality in prostate cancer (PCa) patients. The management of CVD, including hypertension, holds equal significance to cancer treatment ...
Please provide your email address to receive an email when new articles are posted on . HOUSTON — A personalized alert tool may improve use of angiotensin-converting enzyme inhibitors and angiotensin ...
Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...
The European Medicines Agency (EMA) has issued a statement reiterating that people should continue to take certain blood pressure medicines during the COVID-19 pandemic. Recent observational studies, ...
Close-up of senior black woman sorting weekly medication. Member of a black middle class America family. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the ...
No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes. HealthDay News — For individuals with advanced chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results